A cynomolgus monkey model of temporal lobe epilepsy

Area of Science:

• Neuroscience
• Epileptology
• Primate Models

Background:

• Temporal lobe epilepsy (TLE) with hippocampal sclerosis is the most common form of drug-resistant epilepsy.
• Non-human primates offer valuable models for understanding TLE pathogenesis and developing novel therapeutic interventions.

Purpose of the Study:

• To develop and validate a Cynomolgus monkey model of TLE.
• To assess the utility of this model for studying epilepsy mechanisms and potential treatments.

Main Methods:

• Five Cynomolgus monkeys received weekly unilateral hippocampal injections of kainic acid (KA) to induce seizures.
• Video and electroencephalography (EEG) monitored acute seizures and spontaneous recurrent epileptiform discharges (SREDs).
• Interictal epileptiform discharges (IEDs) were assessed three months post-injection under anesthesia.

Main Results:

• EEG confirmed generalized spike discharges in the temporal lobe ipsilateral to KA injection during acute seizures.
• Abundant interictal epileptiform discharges (IEDs) were detected three months later.
• Two monkeys displayed synchronized epileptiform discharges resembling absence seizures; no convulsive symptoms were observed.

Conclusions:

• A viable Cynomolgus monkey model of TLE was successfully established using unilateral hippocampal KA injections.
• This model provides a platform for investigating TLE pathophysiology and evaluating new anti-epileptic drugs.
• The model replicates key features of human TLE, including drug-resistant epilepsy characteristics.